Evoke Pharma (NASDAQ:EVOK) Coverage Initiated by Analysts at StockNews.com
StockNews.com started coverage on shares of Evoke Pharma (NASDAQ:EVOK – Free Report) in a report issued on Thursday morning. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Evoke Pharma Trading Down 4.5 % NASDAQ:EVOK opened at $1.05 on Thursday. The company has a quick ratio of 3.27, a current ratio of […]
More Stories
CBP to Begin First Phase of Tariff Refunds Following Supreme Court Ruling
By Aldgra Fredly U.S. Customs and Border Protection (CBP) is set to begin the first phase of its refund process...
2 US Embassy Employees, 2 Mexican Officials Killed in Car Crash
By Aldgra Fredly Two instructor officers from the U.S. Embassy in Mexico and two Mexican officials died in a car...
Beyond Hormuz: The US–Indonesia Defense Pact and What It Means for China
By Antonio Graceffo The U.S.–Indonesia defense pact strengthens American strategic control over key maritime chokepoints, enhancing its ability to pressure...
Iran Signals It May Skip Next US-Led Peace Talks as Israel Warns of Renewed Fighting
By Tom Ozimek Iran signaled fresh uncertainty around U.S.-backed peace efforts on April 20, saying it has yet to decide...
Is Love Story Season 2 Renewed? Release Date, Cast, and Spoiler
Ryan Murphy’s latest series, Love Story Season 1, has raised the bar with the 90’s romance featuring Sarah Pidgeon and...
Fifty Shades of Grey Star, Dakota Johnson, Net Worth and Salary in 2026
The Fifty Shades of Grey lead actress is once again in the spotlight after she appeared kissing her recent boyfriend,...